Radius Health IPO Research Information

Radius Health IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Radius Health, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Radius Health	RDUS - NASDAQ	$8.00-$8.00	$8.00	$8.03	6.5 million	6/6/2014
Underwriter(s): Jefferies, Cowen & Co.
Co-Manager(s): Canaccord Genuity, Cantor Fitzgerald & Co.
Industry: Health Care
Filing(s): Filed 2012-02-06 Terms Added 2014-04-25 Re-Filed 2014-05-22 Terms Added 2014-06-02

Radius Health Quote & Chart - Click for current quote - RDUS

About Radius Health (adapted from Radius Health prospectus):
They are a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RDUS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.